Navigation Links
Researchers genetically engineer micro-organisms into tiny factories
Date:9/18/2007

BUFFALO, N.Y. -- Microorganisms may soon be efficiently and inexpensively producing novel pharmaceutical compounds, such as flavonoids, that fight aging, cancer or obesity, as well as high-value chemicals, as the result of research being conducted by University at Buffalo researchers.

In work that could transform radically the ways in which many of these compounds are produced commercially, the UB researchers are genetically engineering microorganisms, such as E. coli, into tiny, cellular factories. Several patents related to this work have been filed by UB. The team also is in discussions with companies in the U.S. and abroad.

First Wave Technologies, Inc., a technology development company based in UBs New York State Center of Excellence in Bioinformatics and Life Sciences, which is collaborating with the UB group, recently received a highly competitive Phase I Small Business Innovation Research (SBIR) grant from the National Science Foundation to focus on the biosynthesis of a popular group of flavonoids called isoflavonoids.

Ultimately, we want to be able to take a designed E. coli off of the shelf and drop into it the enzymes that constitute a particular biosynthetic pathway in order to make exactly the product we want, said Mattheos A. G. Koffas, Ph.D., assistant professor of chemical and biological engineering in the School of Engineering and Applied Sciences and leader of the UB team.

The UB approach to synthetic chemistry addresses some of the major challenges in conventional industrial production of specialty chemicals.

Through the use of specially adapted bacteria, specialized enzymes and natural feedstocks, microbial biosynthesis reduces or eliminates the need for petrochemical sources, elevated temperatures, toxic heavy metal catalysts, extremes of acidity and dangerous solvents, Koffas said.

In addition, the natural enzymes the UB researchers are using can facilitate chemical reactions that are difficult to accomplish
'/>"/>

Contact: Ellen Goldbaum
goldbaum@buffalo.edu
716-645-5000 x1415
University at Buffalo
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers identify the early makers of Neonatal Sepsis
4. OHSU Researchers Announce New Discovery
5. Researchers Identify Gene Connected To Bipolar Disorder
6. Ecstasy shrinks brain!!-researchers unveil the secrets of MDMA.
7. Researchers trick Alzheimers Enzyme
8. Researchers find new HIV hiding place
9. Gene researchers make Malaria-resistant mosquito
10. New Hair in 15 Days Could Now Be A Possibility Say Researchers
11. Researchers developed world’s smallest toothbrus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5
...employed to remove abnormal cells in the cervix co..., reveals a new study conducted by researchers at ... good for laser ablation, highlights the study pub...further added that women who need such treatments ...
...nveiled a scheme to eradicate malnutrition among c...and Family Welfare Ajay Vishnoi said. The 'Bal Sh...emented jointly by the public health and the women...rtments, Vishnoi told reporters here. "The scheme...
...hs — a group fascinated by the darker side of huma...icide attempts//. University of Glasgow in Scot...ults several times throughout their teen years. In...aid they were goths admitted to self-harm, and 47 ...
... contact lens solution from the US market on Thurs...close the facts of the // solution, which is impli.... Wal-Mart Stores Inc., Walgreen Co. and other re...olution from their shelves and they were joined on...
Other Medicine News:Health News:Cervical Procedures Increase Risk Of Pregnancy Complications 2
(Date:10/8/2008)...N, France, Oct. 8 /- Vical Incorporat...linical data and new nonclinical data,demonstratin...broadly,applicable in DNA- and protein-based infec...ccines. Alain P. Rolland, Pharm.D., Ph.D., Vical,s...l present the data today,Wednesday, October 8, at...
(Date:10/7/2008)...NT, Mich., Oct. 7 /- McLaren Health C...ring some of the world,s leading medical,minds to ... breast and,gastrointestinal cancer treatments. Th...CI, was organized by McLaren,s Sukamal Saha, M.D.,...n sentinel node mapping for,colorectal cancer has ...
(Date:10/7/2008)...ults of FLEXX Trial Presented at the Osteoarthriti...ress, PARSIPPANY, N.J., Oct. 7 /- Fe...lts from the FLEXX Trial of Osteoarthritis of the,...ate), a highly pure,non-avian high molecular weigh... is superior to intra-articular saline (IA-saline)...
(Date:10/7/2008)...NNA, Va., Oct. 7 /- CEL-SCI... has entered into a Material Transfer,Agreement (M...l Center,(NIHCC) and the laboratory of Dr. Frances...r basis of changes to the tumor microenvironment,c...ncola is the Chief of,the Infectious Disease and I...
Breaking Medicine Technology:Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana 4233 1BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana 4233 2BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana 4233 3Trubion Initiates Phase 1 2 Study of TRU 016 in CLL Announces Next Generation Product Candidate for RA and Provides Product Pipeline Update 1607 1Trubion Initiates Phase 1 2 Study of TRU 016 in CLL Announces Next Generation Product Candidate for RA and Provides Product Pipeline Update 1607 2Trubion Initiates Phase 1 2 Study of TRU 016 in CLL Announces Next Generation Product Candidate for RA and Provides Product Pipeline Update 1607 3Trubion Initiates Phase 1 2 Study of TRU 016 in CLL Announces Next Generation Product Candidate for RA and Provides Product Pipeline Update 1607 4Trubion Initiates Phase 1 2 Study of TRU 016 in CLL Announces Next Generation Product Candidate for RA and Provides Product Pipeline Update 1607 5FDA Probing Possible Link Between Asthma Drug and Suicide Risk 15339 1FDA Probing Possible Link Between Asthma Drug and Suicide Risk 15339 2FDA Probing Possible Link Between Asthma Drug and Suicide Risk 15339 3Insights on Paying for Boomers Care Needs in 20 40 Years Helped by New Report 15337 1Insights on Paying for Boomers Care Needs in 20 40 Years Helped by New Report 15337 2Insights on Paying for Boomers Care Needs in 20 40 Years Helped by New Report 15337 3Insights on Paying for Boomers Care Needs in 20 40 Years Helped by New Report 15337 4Insights on Paying for Boomers Care Needs in 20 40 Years Helped by New Report 15337 5
...p; Tolerability Profile,in Subjects with Type 2 Di...2007 /PRNewswire-FirstCall/ -- Phase III data,pres...can Diabetes,Association demonstrated that saxagli...4) in development by Bristol-Myers,Squibb Company ...xhibited a statistically significant improvement i...
... 2007 - Columbia,Laboratories, Inc. (NASDAQ: CBRX)...completed multi-dose pharmacokinetic study of,vagi... developing,to prevent and treat dysmenorrhea., Th...n blood,levels associated with the Company,s bioad... strengths over multiple doses. The cohort,was ran...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6Columbia Laboratories Reports Positive Results from Multi-dose,Pharmacokinetic Study of Vaginally-administered Lidocaine 2Columbia Laboratories Reports Positive Results from Multi-dose,Pharmacokinetic Study of Vaginally-administered Lidocaine 3
Detection of antibodies to Malaria in Human whole blood.
Paracheck Pf is a two site sandwich immunoassay for the detection of P. falciparum specific histidine rich protein 2 (Pf HRP-2) in whole blood samples.
This is an antigen-capture assay intended for the detection of histidine-rich protein ll (PfHRP-ll), which is released from Malaria-infected red blood cells.
The Malaria Combo Test is a rapid test for the qualitative detection of Plasmodium falciparum and / or Plasmodium vivax , Plasmodium ovale and Plasmodium malariae antigen in whole blood. This
Medicine Products: